Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Delisting risk
confidence 92%
filed 2026-09-22
EX-99.1
The exhibit discloses that Immutep received a Nasdaq deficiency notice on 30 April 2026 for failing to maintain a minimum bid price of US$1.00 for 30 consecutive business days, triggering a compliance period ending 26 October 2026. The ADS ratio change (1:20 reverse split) is explicitly a "technical step directed at that requirement" to regain compliance. This is a material delisting risk disclosure under Item 3.01, as the company faces potential delisting if it cannot achieve the required minimum bid price within the compliance window.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-22
Item 1.01
Aon plc entered into material credit agreements on September 18, 2026—a $4 billion delayed draw term loan facility and a $3 billion unsecured revolving credit facility—to fund the USI Acquisition, while terminating two existing revolving credit facilities. The financing arrangements are explicitly tied to the acquisition and represent a refinancing of the company's capital structure to support the material M&A transaction.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-09-22
Item 1.01
Henry Schein amended and restated its revolving credit facility, increasing aggregate commitments from $1 billion to $1.25 billion and extending the termination date to September 19, 2031. This amendment constitutes a material creation of a direct financial obligation and represents a significant capital structure event for the company.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-09-22
Item 8.01
Viking Therapeutics announced positive top-line results from a clinical maintenance study of its lead candidate VK2735, a GLP-1/GIP agonist. The press release discloses detailed efficacy and safety data from a Phase 2 maintenance study, including weight loss percentages, maintenance rates across dosing regimens, and adverse event profiles. This constitutes a material clinical trial result disclosure that would significantly affect investor assessment of the company's pipeline and commercial prospects for its obesity treatment candidate.
View raw filing on EDGAR →
8-K
M&A activity
confidence 97%
filed 2026-09-22
Item 1.01
Lexeo Therapeutics entered into a definitive Agreement and Plan of Merger on September 16, 2026, to acquire Mantle Therapeutics Inc. for $8.3 million in upfront consideration (cash and equity) plus up to $13.0 million in contingent milestone payments, totaling up to $21.3 million. The acquisition brings four therapeutic candidates (LX3010, LX3030, LX3050, LX3070) designed to address Friedreich ataxia, materially expanding Lexeo's platform and pipeline.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-22
Item 7.01
The disclosure announces receipt of 3,400 railcar orders valued at approximately $600 million during fiscal Q4, including a significant 780-unit order from Saudi Railway Company (SAR) representing Greenbrier's first intermodal sale to that customer. This is a material operational/commercial event reflecting customer demand and business activity, but it is not a financial results disclosure (earnings_release), which would typically be a comprehensive quarterly earnings announcement. The Item 7.01 Regulation FD Disclosure classification and the press release format indicate this is a selective disclosure of significant order activity rather than a full earnings report.
View raw filing on EDGAR →
8-K
M&A activity
confidence 80%
filed 2026-09-22
Item 5.01
Blackstone affiliates, the majority owners of Jersey Mike's Subs Inc., have pledged approximately 54.3% of the Company's outstanding Class A Common Stock and related Common Units as collateral for approximately $1.09 billion in margin loan agreements with Morgan Stanley. This pledge arrangement creates potential change-of-control risk and represents a material transaction affecting the registrant's ownership structure and control.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-09-22
Item 5.02
Adam L. Rosman resigned as Chief Administrative Officer and Chief Legal Officer effective September 30, 2026. While the disclosure also mentions Eric C. Nelson's appointment as successor Chief Legal Officer, the principal disclosed action is Rosman's departure from two senior officer roles. This is material to investors as it involves a C-suite executive departure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 90%
filed 2026-09-22
Item 7.01
Solaris Energy Infrastructure announced an intended offering of $1.0 billion aggregate principal amount of Senior Notes due 2032 by its subsidiary in a private placement under Rule 144A and Regulation S, with net proceeds designated for general corporate purposes, growth capital expenditures, and offering-related fees.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-09-22
Item 7.01
The disclosure announces positive results from a feasibility study for the Granite Creek Underground gold project, including initial mineral reserves (556,500 oz Au), expanded mineral resources (859,500 oz Au measured and indicated), and project economics (after-tax NPV of $118M at $2,750/oz Au). This is a material operational and strategic milestone for a mining company's development project, but does not fit the specific categories of earnings release, M&A activity, material impairment, or other defined event types. The feasibility study represents a significant advancement in project development and mine planning that would affect investor assessment of the company's operational prospects and asset value.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-22
Item 8.01
LandBridge announced the launch of a $100 million offering of 6.250% senior notes due 2030 as additional notes under an existing indenture, with net proceeds intended to repay a portion of outstanding borrowings under its revolving credit facility.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-22
Item 8.01
Millrose announced the launch of a $1.0 billion senior notes offering in two tranches ($500 million due 2029 and $500 million due 2031), creating a new direct financial obligation. The filing explicitly states the company "plans to offer" these notes and intends to use proceeds for general corporate purposes including potential acquisitions and repayment of existing revolving credit facility borrowings. This is a material debt issuance event under Item 2.03 taxonomy, distinct from a covenant breach or other debt-related trouble.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-22
Item 2.03
Columbus McKinnon amended its existing credit agreement on September 21, 2026, repricing its $1,453 million Term Loan B and $500 million Revolving Credit Facility by reducing the applicable interest rate margin by 50 basis points. The repricing is expected to reduce annual cash interest expense by at least $7.3 million, materially affecting the company's direct financial obligations and debt structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-09-22
Item 5.02
Jamaal T. Lesane's appointment as Executive Vice President and Chief Legal Officer is the principal disclosed action. While the filing also mentions his departure from the COO role and Bryan Warner's loss of executive officer status, the salient event is Lesane's elevation to a C-suite legal position, which is material to investors assessing leadership and governance. The appointment of a Chief Legal Officer is a significant executive change warranting disclosure.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-22
Item 8.01
The filing discloses supplemental disclosures related to a previously announced merger agreement dated May 27, 2026, whereby Merger Sub (a subsidiary of Fertitta Entertainment) will merge with Caesars Entertainment, with Caesars continuing as a wholly owned subsidiary of Fertitta Entertainment. Although the Item 8.01 disclosure is primarily responsive to a stockholder demand letter regarding counsel conflicts of interest, the underlying material event is the merger transaction itself, which is a change of control and material acquisition activity. The supplemental disclosures are made to address potential litigation risks that could delay or adversely affect the Merger, underscoring its materiality to investors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-09-22
Item 8.01
The filing discloses an updated Pre-Feasibility Study (PFS) for the Granite Creek Underground Project, including updated mineral resource and reserve estimates, project economics (NPV of $118M after-tax, 8.5-year mine life, 485,000 oz total gold recovery), and detailed technical parameters. This represents a material operational and strategic milestone for the mining project, superseding the prior PEA from March 2025. The PFS demonstrates economic viability and provides the technical foundation for development decisions, making it material to investors' assessment of the company's mining operations and asset value.
View raw filing on EDGAR →
8-K
Financial Other
confidence 85%
filed 2026-09-22
Item 8.01
This disclosure reports the Fund's Net Asset Value (NAV) per share as of July 31, 2026 ($24.704), along with aggregate NAV ($608.9 million), portfolio fair value ($1,160.3 million), debt outstanding ($559.2 million), and debt-to-equity ratio (0.92x). NAV reporting is a material financial disclosure for a closed-end fund that would affect investor assessment of the fund's value and leverage position, but does not fit a specific financial event category (not earnings, impairment, debt issuance, or dividend). This is routine periodic NAV disclosure under Item 8.01, classified as financial_other.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Vista Credit Strategic Lending Corp. completed an unregistered sale of 124,395.879 shares of Class I common stock for $2,396,300 to accredited investors and non-U.S. persons, relying on Section 4(a)(2) and Regulation D/S exemptions.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-22
Item 8.01
The Company disclosed preliminary net asset value (NAV) per share of $19.26 as of August 31, 2026, along with total investments of $2.2 billion and a debt-to-equity ratio of 0.97x, providing material metrics for investor assessment of the registrant's financial condition and leverage position.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-22
Item 1.01
Heritage Global entered into a $10.0 million revolving line of credit with C3bank on September 16, 2026, governed by a promissory note, business loan agreement, and commercial security agreement. The facility carries an interest rate of prime plus 1.00% (floor 7.500%), matures on January 16, 2028, and includes customary covenants.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-09-22
Item 8.01
Biomea Fusion disclosed an update to the anticipated timing of topline results from its Phase I GLP-131 trial for BMF-650, now expected in October 2026. This is a material clinical trial milestone update for a biopharmaceutical company, representing progress toward regulatory and commercial objectives. While not fitting a specific named event type, this operational/strategic disclosure affects investor assessment of the company's pipeline and development trajectory.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-22
Item 2.03
Blue Owl Credit Income Corp. completed a $1.0 billion notes offering ($700 million 6.250% notes due 2029 and $300 million 6.550% notes due 2031) and amended its senior secured revolving credit facility, increasing total capacity to $4.2 billion and extending maturity to September 2031. These transactions represent approximately $1.3 billion of total debt capital raised since June 30, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 98%
filed 2026-09-22
Item 2.03
Tenet Healthcare issued $2 billion in aggregate principal amount of 6.250% senior notes due 2034 pursuant to an indenture dated September 22, 2026. The company intends to use net proceeds to refinance existing debt obligations ($1.5 billion of 2027 Notes and $0.5 billion of 2028 Notes).
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-09-22
EX-99.1
This exhibit discloses the voting results from Silicon Motion's 2026 Annual General Meeting of Shareholders held on September 22, 2026. It reports the outcomes of two shareholder proposals: (1) re-election of directors Tsung-Ming Chung and Steve Chen, and (2) ratification of Deloitte & Touche as independent auditors. The document explicitly states "The final voting results for each proposal are set forth below" and confirms both proposals passed as ordinary resolutions, making this a clear shareholder_vote_results disclosure under Item 5.07 equivalent.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-09-22
Item 8.01
The filing discloses the declaration of a third quarter 2026 supplemental dividend of $0.02 per share, payable on October 13, 2026 to shareholders of record as of September 25, 2026. This is a clear dividend distribution event. As a BDC, dividend distributions are material to shareholders and affect the total return profile of the investment.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 85%
filed 2026-09-22
Item 8.01
LeonaBio disclosed the exercise of Series A Common Warrants issued in a December 2025 private placement, covering 23,031,494 shares with an exercise price of $6.35 per share. The warrants became exercisable on September 18, 2026, and represent a potential $146.2 million capital raise if fully exercised. This is a dilutive equity issuance tied to a prior private placement, material to investors assessing capital structure and shareholder dilution risk.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-09-22
Item 2.02
Worthington Enterprises issued a news release reporting fiscal 2027 first quarter results for the three-month period ended August 31, 2026, with net sales of $343.9 million (up 13%), net earnings of $42.6 million (up 22%), and EPS of $0.87.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-22
Item 8.01
The Board declared a quarterly cash dividend of $0.20 per share, payable on December 29, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-09-22
Item 7.01
Medallion Bank announced the launch of a public offering of non-cumulative perpetual preferred stock (Series G), which constitutes the creation of a new direct financial obligation. The press release explicitly states this is a reopening of the original Series G issuance and discloses the use of net proceeds for general corporate purposes, including potential redemption of existing Series E Preferred Stock. This is a material capital-raising event affecting the registrant's financial structure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 96%
filed 2026-09-22
Item 2.03
Group 1 Automotive completed a private offering of $1.25 billion in aggregate principal amount of senior unsecured notes ($625 million due 2032 at 6.250% and $625 million due 2035 at 6.625%), receiving net proceeds of approximately $1.236 billion. The proceeds are intended to fund the Hennessy Acquisition and related expenses.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-22
Item 7.01
First Eagle Private Credit Fund declared regular distributions to shareholders of $0.210 per share (gross) for both Class I and Class D common shares, with a record date of September 30, 2026 and payment date of October 29, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 1.01
Alaunos Therapeutics entered into a securities purchase agreement on September 18, 2026, to sell 380,469 shares of common stock and 386,654 pre-funded warrants at $1.46 per share in a registered direct offering, raising approximately $915,400 to $1.1 million in proceeds for general corporate purposes.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Apollo Debt Solutions BDC sold 357,105 unregistered Class I Common Shares for $8.5 million to feeder vehicles, relying on Section 4(a)(2) and Regulation S exemptions from Securities Act registration.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-09-22
Item 7.01
The company declared distributions for each class of common shares on September 22, 2026, with a gross per-share amount of $0.1800 for all classes, payable to shareholders of record as of September 30, 2026, and to be paid on or around October 29, 2026.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-22
Item 1.01
Halozyme completed the sale of $1,500.0 million aggregate principal amount of 1.50% Convertible Senior Notes due 2033 on September 22, 2026, with net proceeds of approximately $1,471.1 million intended for debt repurchases, general corporate purposes, and potential acquisitions. The convertible notes are convertible into up to 13,676,100 shares of common stock at a conversion rate of 9.1174 shares per $1,000 principal amount, creating both a direct financial obligation and potential equity dilution.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-09-22
Item 7.01
LandBridge announced the pricing of $125 million in aggregate principal amount of 6.250% senior notes due 2030, issued as additional notes under an existing indenture. The company intends to use net proceeds to repay revolving credit facility borrowings.
View raw filing on EDGAR →
8-K
M&A activity
confidence 96%
filed 2026-09-22
Item 2.01
Talos Energy completed a strategic acquisition of deepwater Gulf of America assets from Shell Offshore Inc. for $420 million net cash, acquiring a 50% working interest and operatorship of the Coulomb field and a 25% non-operated interest in the Na Kika platform and related fields. The transaction enhances the company's asset base, production capacity, and operational scale in the Gulf of Mexico.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-09-22
Item 5.02
Carianne Marshall's departure as Co-Chair and Chief Operating Officer of Warner Chappell Music (a subsidiary) is the principal disclosed action, effective September 30, 2026. While the filing also details severance and compensation arrangements, the core event is her stepping down from a senior executive role. The materiality is supported by the significant severance package (18 months salary plus $1.5M equity award), indicating a senior-level departure that would affect investor assessment of leadership continuity.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 95%
filed 2026-09-22
Vista Energy announces completion of pricing for U.S.$400 million in aggregate principal amount of 7.875% senior notes due 2038 issued by its main subsidiary Vista Energy Argentina S.A.U., with closing expected October 9, 2026. This is a material creation of a direct financial obligation under Item 2.03, increasing the subsidiary's total 2038 Notes outstanding to U.S.$900 million. The issuance is material to investors assessing the registrant's capital structure and leverage.
View raw filing on EDGAR →
8-K
Financial Other
confidence 75%
filed 2026-09-22
Item 7.01
Blackstone disclosed a preliminary estimate of over $350 million in Realized Performance Revenues and Realized Principal Investment Income for the period July 1 to September 22, 2026. This is an intra-quarter realization update that provides forward-looking financial guidance on a specific revenue component. While not a full earnings release (which would typically come at quarter-end), this disclosure of material revenue expectations would affect a reasonable investor's assessment of the company's near-term financial performance and is material to the total mix of information available.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-09-22
Item 1.01
Fortress Private Lending Fund amended its senior secured revolving credit facility, increasing the maximum principal amount from $400 million to $500 million, extending the revolver availability period to September 2030 and maturity date to September 2031, and adding an accordion provision permitting increases up to $1 billion.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Fortress Private Lending Fund sold 1,065,109 Class I common shares for $25.8 million in aggregate consideration to accredited investors pursuant to Section 4(a)(2) and Regulation D exemptions.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 92%
filed 2026-09-22
Item 8.01
Fortress Private Lending Fund declared a monthly distribution of $0.1834 per Class I share for September 2026, payable on or about October 22, 2026.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-09-22
Item 1.01
Haymaker Acquisition Corp V consummated its initial public offering on September 18, 2026, raising $287.5 million through the issuance of 28.75 million units pursuant to multiple material definitive agreements including an underwriting agreement, warrant agreement, trust agreement, and registration rights agreement. As a blank-check SPAC, the IPO represents a material capital-raising event that will fund future business combination activity.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Simultaneously with the IPO closing, Haymaker sold 5,333,333 unregistered warrants to the Sponsor and Underwriters at $1.50 per warrant ($8.0 million aggregate) pursuant to Section 4(a)(2) exemption, exercisable for Class A ordinary shares at $11.50 per share. This private placement represents a material dilutive issuance of equity securities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-09-22
Item 5.07
Houlihan Lokey held its Annual Meeting of Stockholders with final vote tabulations on four proposals: election of Class II directors, advisory vote on executive compensation, ratification of KPMG LLP as independent auditor, and approval of the Second Amended and Restated 2016 Incentive Award Plan.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-09-22
Item 7.01
Prabha Sipi Bhandari was appointed as Chief Legal Officer and Corporate Secretary, assuming responsibility for all legal and compliance activities globally, while Christopher M. Crain transitioned to Corporate Senior Advisor.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-09-22
Item 8.01
M&T Bank Corporation refreshed its Medium-Term Note Program to issue Senior Medium-Term Notes, Series C and Subordinated Medium-Term Notes, Series D under existing indentures dated May 24, 2007 and September 22, 2023, respectively. This constitutes creation of a new direct financial obligation through a debt issuance program, which is a material capital event for a bank. The disclosure of the registration statement (Form S-3, File No. 333-299064) and the Officers' Certificates establishing the terms confirm the establishment of new debt issuance capacity.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-09-22
Item 5.02
Kyle Miller was elected President of United Parks & Resorts effective September 22, 2026, following a 31-year tenure with the company and prior service as Chief Parks Operations Officer. The appointment includes detailed compensation arrangements comprising a base salary of $400,000, bonus and long-term incentive targets, and equity grants totaling $2.5 million.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-09-22
Item 3.02
Goldman Sachs Private Credit Corp. completed an unregistered sale of approximately $94 million in Class I and Class S shares to accredited investors and non-U.S. persons, exempt under Section 4(a)(2), Regulation D, and Regulation S.
View raw filing on EDGAR →